Literature DB >> 11772849

Heritability of Schneider's first-rank symptoms.

Alastair G Cardno1, Pak C Sham, Anne E Farmer, Robin M Murray, Peter McGuffin.   

Abstract

BACKGROUND: Schneider's first-rank symptoms are given particular weight when making a diagnosis of schizophrenia, but the nuclear syndrome, characterised by one or more first-rank symptoms, has been found previously to have no heritability. AIMS: To estimate the heritability of the nuclear syndrome.
METHOD: A total of 224 twin pairs (106 monozygotic, 118 same-gender dizygotic) were ascertained from the Maudsley Twin Register in London via probands with any psychosis. Lifetime-ever first-rank symptoms were rated using the OPCRIT checklist. Probandwise concordance rates were calculated for the nuclear syndrome and a heritability estimate was derived from biometric model fitting.
RESULTS: Probandwise concordance rates were 13/49 (26.5%) for monozygotic and 0/45 to 2/46 (0.0-4.3%) for dizygotic pairs. The heritability estimate for the best-fitting model was 71% (95% CI 57-82).
CONCLUSIONS: These results indicate that the nuclear syndrome shows substantial heritability, although this is slightly lower than that for schizophrenia as defined by the DSM and ICD systems.

Entities:  

Mesh:

Year:  2002        PMID: 11772849     DOI: 10.1192/bjp.180.1.35

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  10 in total

Review 1.  First rank symptoms for schizophrenia.

Authors:  Karla Soares-Weiser; Nicola Maayan; Hanna Bergman; Clare Davenport; Amanda J Kirkham; Sarah Grabowski; Clive E Adams
Journal:  Cochrane Database Syst Rev       Date:  2015-01-25

Review 2.  Genetics of developmental psychiatric disorders: pathways to discovery.

Authors:  Ridha Joober; Sarojini Sengupta; Patricia Boksa
Journal:  J Psychiatry Neurosci       Date:  2005-09       Impact factor: 6.186

3.  The genetics of schizophrenia.

Authors:  Mohd Razali Salleh
Journal:  Malays J Med Sci       Date:  2004-07

Review 4.  Competing definitions of schizophrenia: what can be learned from polydiagnostic studies?

Authors:  Lennart B Jansson; Josef Parnas
Journal:  Schizophr Bull       Date:  2006-12-08       Impact factor: 9.306

Review 5.  Biological, life course, and cross-cultural studies all point toward the value of dimensional and developmental ratings in the classification of psychosis.

Authors:  Rina Dutta; Talya Greene; Jean Addington; Kwame McKenzie; Michael Phillips; Robin M Murray
Journal:  Schizophr Bull       Date:  2007-06-11       Impact factor: 9.306

6.  Fine mapping on chromosome 10q22-q23 implicates Neuregulin 3 in schizophrenia.

Authors:  Pei-Lung Chen; Dimitrios Avramopoulos; Virginia K Lasseter; John A McGrath; M Daniele Fallin; Kung-Yee Liang; Gerald Nestadt; Ningping Feng; Gary Steel; Andrew S Cutting; Paula Wolyniec; Ann E Pulver; David Valle
Journal:  Am J Hum Genet       Date:  2009-01       Impact factor: 11.025

Review 7.  [Endophenotype--a new concept for biological characterization of psychiatric disorders].

Authors:  A Zobel; W Maier
Journal:  Nervenarzt       Date:  2004-03       Impact factor: 1.214

Review 8.  A review of the reliability and validity of OPCRIT in relation to its use for the routine clinical assessment of mental health patients.

Authors:  Philip J Brittain; Daniel Stahl; James Rucker; Jamie Kawadler; Gunter Schumann
Journal:  Int J Methods Psychiatr Res       Date:  2013-05-09       Impact factor: 4.035

9.  The diagnostic concept of schizophrenia: its history, evolution, and future prospects.

Authors:  Assen Jablensky
Journal:  Dialogues Clin Neurosci       Date:  2010       Impact factor: 5.986

10.  The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study.

Authors:  Diego Quattrone; Ulrich Reininghaus; Alex L Richards; Giada Tripoli; Laura Ferraro; Andrea Quattrone; Paolo Marino; Victoria Rodriguez; Edoardo Spinazzola; Charlotte Gayer-Anderson; Hannah E Jongsma; Peter B Jones; Caterina La Cascia; Daniele La Barbera; Ilaria Tarricone; Elena Bonora; Sarah Tosato; Antonio Lasalvia; Andrei Szöke; Celso Arango; Miquel Bernardo; Julio Bobes; Cristina Marta Del Ben; Paulo Rossi Menezes; Pierre-Michel Llorca; Jose Luis Santos; Julio Sanjuán; Manuel Arrojo; Andrea Tortelli; Eva Velthorst; Steven Berendsen; Lieuwe de Haan; Bart P F Rutten; Michael T Lynskey; Tom P Freeman; James B Kirkbride; Pak C Sham; Michael C O'Donovan; Alastair G Cardno; Evangelos Vassos; Jim van Os; Craig Morgan; Robin M Murray; Cathryn M Lewis; Marta Di Forti
Journal:  Transl Psychiatry       Date:  2021-08-10       Impact factor: 6.222

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.